Search: onr:"swepub:oai:prod.swepub.kib.ki.se:120046051" >
Patients with del(5...
Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression
- Article/chapterEnglish2010
Publisher, publication year, extent ...
-
2009-10-24
-
Springer Science and Business Media LLC,2010
Numbers
-
LIBRIS-ID:oai:prod.swepub.kib.ki.se:120046051
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:120046051URI
-
https://doi.org/10.1007/s00277-009-0846-zDOI
Supplementary language notes
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Added entries (persons, corporate bodies, meetings, titles ...)
-
Giagounidis, A
(author)
-
Busche, G
(author)
-
Kreipe, HH
(author)
-
Zimmermann, M
(author)
-
Hellstrom-Lindberg, EKarolinska Institutet
(author)
-
Aul, C
(author)
-
Schlegelberger, B
(author)
-
Karolinska Institutet
(creator_code:org_t)
Related titles
-
In:Annals of hematology: Springer Science and Business Media LLC89:4, s. 365-3741432-05840939-5555
Internet link
Find in a library
To the university's database